Ehsan Dadgostar

Ehsan Dadgostar

Auto-generated profile, based on publicly available information

Ehsan Dadgostar

Halal Research Center of IRI, FDA, Tehran, Iran

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Neurochemistry International
Verified
Journal Article
Closed access
MTMohsen Taghizadeh
Mohsen Taghizadeh
OTOmid Reza Tamtaji
Omid Reza Tamtaji
EDEhsan Dadgostar
Ehsan Dadgostar
RKReza Daneshvar Kakhaki
Reza Daneshvar Kakhaki
FBFereshteh Bahmani
Fereshteh Bahmani
ZAZatollah Asemi
Zatollah Asemi

13 November 2018 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
RTReza Tabrizi
Reza Tabrizi
OTOmid Reza Tamtaji
Omid Reza Tamtaji
KLKamran B. Lankarani
Kamran B. Lankarani
MAMaryam Akbari
Maryam Akbari
EDEhsan Dadgostar
Ehsan Dadgostar
ZAZatollah Asemi
Zatollah Asemi
This systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to summarize the effect of resveratrol intake on weight loss. We searched the following databases until July 2018: MEDLINE, EMBASE, Web of Science and Cochrane Central Register of Controlled Trials. Data were pooled using the inverse variance method and expressed as standardized mean difference (SMD) with 95% confidence intervals (95% CI). Out of 831 reports, 36 RCTs were eligible for including to our meta-analysis. The pooled results, using random-effects model showed that resveratrol supplementation significantly decreased body weight (SMD = -0.17; 95% CI, -0.33, -0.01; P = 0.03; I2: 62.6), body mass index (BMI) (SMD = -0.20; 95% CI, -0.35, -0.05; P = 0.01; I2: 60.6), fat mass (SMD = -0.32; 95% CI, -0.62, -0.03; P = 0.03; I2: 77.9) and waist circumference (WC) (SMD = -0.42; 95% CI, -0.68, -0.16; P = 0.001; I2: 75.2), and significantly increased lean mass (SMD = 1.21; 95% CI, 0.75, 1.67; P < 0.001; I2: 87.6). We found no significant effect of resveratrol administration on leptin (SMD = -0.20; 95% CI, -0.68, 0.27; P = 0.40; I2: 85.3) and adiponectin levels (SMD = 0.08; 95% CI, -0.39, 0.55; P = 0.74; I2: 91.0). Resveratrol supplementation significantly decreased body weight in obese patients (SMD -0.43; 95% CI, -0.60, -0.26) compared with other diseases (SMD 0.02; 95% CI, -0.29, 0.33), and type 2 diabetes mellitus (SMD -0.17; 95% CI, -0.37, 0.02). Overall, the current meta-analysis demonstrated that resveratrol intake significantly reduced weight, BMI, WC and fat mass, and significantly increased lean mass, but did not affect leptin and adiponectin levels.

6 August 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
RGRoya Ghasemian
Roya Ghasemian
ASAmir Shamshirian
Amir Shamshirian
KHKeyvan Heydari
Keyvan Heydari
MMMohammad Malekan
Mohammad Malekan
RAReza Alizadeh-Navaei
Reza Alizadeh-Navaei
DSDanial Shamshirian
Danial Shamshirian

24 April 2019 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
RTReza Tabrizi
Reza Tabrizi
OTOmid Reza Tamtaji
Omid Reza Tamtaji
NMNaghmeh Mirhosseini
Naghmeh Mirhosseini
KLKamran Bagheri Lankarani
Kamran Bagheri Lankarani
MAMaryam Akbari
Maryam Akbari
ZAZatollah Asemi
Zatollah Asemi
Aims: This systematic review and meta-analysis of randomized controlled trials (RCTs) was performed to determine the effect of quercetin administration on lipid profiles and inflammatory markers among patients with metabolic syndrome (MetS) and related disorders. Methods: We searched systematically online databases including Cochrane Library, EMBASE, MEDLINE, and Web of Science to identify the relevant RCTs until November 2018. Q-test and I2 statistics were applied to assess heterogeneity among included studies. Data were combined using fixed- or random-effects model and presented as standardized mean difference (SMD) with 95% confidence interval (CI). Results: Out of 591 citations, 16 RCTs were included in the meta-analysis. The pooled findings showed that quercetin consumption significantly decreased total-cholesterol (SMD = −0.98; 95% CI, −1.48, −0.49; p < 0.001; I2: 94.0), LDL-cholesterol (SMD = −0.88; 95% CI, −1.35, −0.41; p < 0.001; I2: 92.7) and C-reactive protein (CRP) levels (−0.64; 95% CI, −1.03, −0.25; p = 0.001; I2: 90.2). While, quercetin supplementation did not significantly affect triglycerides (TG) (SMD = −0.32; 95% CI, −0.68, 0.04; p = 0.08; I2: 84.8), HDL-cholesterol (SMD = 0.20; 95% CI, −0.20, 0.24; p = 0.84; I2: 70.6), interleukin 6 (IL-6) (SMD = −0.69; 95% CI, −1.69, 0.31; p = 0.17; I2: 94.5) and tumor necrosis factor-alpha (TNF-α) levels (SMD = −0.06; 95% CI, −0.25, 0.14; p = 0.58; I2: 35.6) Conclusions: In summary, the current meta-analysis demonstrated that quercetin supplementation significantly reduced total-cholesterol, LDL-cholesterol, and CRP levels, yet did not affect triglycerides, HDL-cholesterol, IL-6 and TNF-α among patients with MetS and related disorders.

1 March 2018 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
EKEbrahim Kouchaki
Ebrahim Kouchaki
RKReza Daneshvar Kakhaki
Reza Daneshvar Kakhaki
OTOmid Reza Tamtaji
Omid Reza Tamtaji
EDEhsan Dadgostar
Ehsan Dadgostar
MBMohammad Behnam
Mohammad Behnam
HAHossein Akbari
Hossein Akbari

6 August 2019 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
OTOmid Reza Tamtaji
Omid Reza Tamtaji
RRRussel J. Reiter
Russel J. Reiter
RAReza Alipoor
Reza Alipoor
EDEhsan Dadgostar
Ehsan Dadgostar
EKEbrahim Kouchaki
Ebrahim Kouchaki
ZAZatollah Asemi
Zatollah Asemi